HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heng Mei Selected Research

Cell- and Tissue-Based Therapy (Cell Therapy)

1/2021PiggyBac-Generated CAR19-T Cells Plus Lenalidomide Cause Durable Complete Remission of Triple-Hit Refractory/Relapsed DLBCL: A Case Report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Heng Mei Research Topics

Disease

22Neoplasms (Cancer)
02/2022 - 04/2011
11COVID-19
05/2022 - 01/2020
11Thrombosis (Thrombus)
12/2020 - 01/2015
7Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 01/2015
6Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2022 - 08/2020
6Disseminated Intravascular Coagulation
01/2020 - 01/2017
5Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 08/2011
5Leukemia
11/2020 - 04/2011
4Multiple Myeloma
01/2022 - 11/2018
4Glioma (Gliomas)
01/2021 - 12/2013
3Inflammation (Inflammations)
02/2022 - 01/2020
3Thrombocytopenia (Thrombopenia)
01/2022 - 09/2020
3Hemorrhage
01/2022 - 08/2020
3Hypoxia (Hypoxemia)
12/2021 - 01/2020
3Cytokine Release Syndrome
01/2020 - 01/2018
3Infarction (Infarctions)
06/2018 - 05/2013
2Sepsis (Septicemia)
02/2022 - 01/2020
2Respiratory Tract Infections (Respiratory Tract Infection)
01/2022 - 01/2021
2Urinary Tract Infections (Urinary Tract Infection)
01/2022 - 01/2021
2Lymphoma (Lymphomas)
01/2021 - 01/2020
2Atherosclerotic Plaque (Atheroma)
01/2019 - 10/2012
2Myocardial Infarction
06/2011 - 01/2009
1Endotoxemia
02/2022
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022
1Thrombophilia
01/2022
1Autoimmune Diseases (Autoimmune Disease)
01/2022
1Colitis
12/2021
1Ulcer
12/2021
1Mitochondrial Diseases (Mitochondrial Disease)
08/2021
1Glioblastoma (Glioblastoma Multiforme)
01/2021
1Hematuria
01/2021

Drug/Important Bio-Agent (IBA)

10Chimeric Antigen ReceptorsIBA
01/2022 - 07/2019
8Pharmaceutical PreparationsIBA
02/2022 - 12/2013
8Dacarbazine (DIC)FDA LinkGeneric
01/2020 - 01/2015
8Thromboplastin (Tissue Factor)IBA
01/2020 - 10/2012
7Proteins (Proteins, Gene)FDA Link
12/2021 - 05/2013
6Inosine Triphosphate (ITP)IBA
01/2022 - 08/2020
5Paclitaxel (Taxol)FDA LinkGeneric
12/2017 - 12/2013
4fibrin fragment D (D-dimer)IBA
01/2021 - 01/2020
3Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2008
3hetrombopagIBA
01/2022 - 01/2021
3AntigensIBA
01/2022 - 02/2020
3FibrinIBA
04/2021 - 01/2016
3Therapeutic UsesIBA
02/2020 - 01/2016
3polyethylene glycol-poly(lactide-co-glycolide)IBA
01/2020 - 05/2013
2Thrombopoietin ReceptorsIBA
01/2022 - 01/2021
2AutoantibodiesIBA
01/2022 - 01/2022
2Thrombopoietin (c-mpl Ligand)IBA
01/2022 - 12/2021
2tocilizumab (atlizumab)FDA Link
01/2022 - 01/2022
2Interleukin-6 (Interleukin 6)IBA
01/2022 - 07/2016
2Indicators and Reagents (Reagents)IBA
12/2020 - 04/2011
2MicellesIBA
08/2020 - 01/2016
2Oxygen (Dioxygen)IBA
01/2020 - 05/2017
2CytokinesIBA
01/2020 - 01/2020
21-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2020 - 05/2017
2enhanced green fluorescent proteinIBA
01/2019 - 01/2019
2Tissue Plasminogen Activator (Alteplase)FDA Link
06/2018 - 01/2016
1Immunoglobulins (Immunoglobulin)IBA
05/2022
1Simvastatin (Zocor)FDA LinkGeneric
02/2022
1EndotoxinsIBA
02/2022
1Messenger RNA (mRNA)IBA
01/2022
16-methyladenineIBA
01/2022
1Complement System Proteins (Complement)IBA
01/2022
1N-methyladenosineIBA
01/2022
1Complement C3a (Complement 3a)IBA
01/2022
1Bortezomib (Velcade)FDA Link
01/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1Mesalamine (Mesalazine)FDA LinkGeneric
12/2021
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
12/2021
1HydrogelsIBA
12/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2021
1eltrombopagFDA Link
12/2021
1PolymersIBA
12/2021
1Interleukin-4 (Interleukin 4)IBA
10/2021
1Interleukin-17 (Interleukin 17)IBA
10/2021
1perforin-granzyme BIBA
10/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2021
1Interleukin-2 (IL2)IBA
10/2021
1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
10/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
08/2021
1DNA (Deoxyribonucleic Acid)IBA
08/2021
1Cisplatin (Platino)FDA LinkGeneric
08/2021
1Succinic Acid (Succinate)IBA
08/2021
1Biocompatible Materials (Biomaterials)IBA
04/2021
1taxifolinIBA
01/2021
1Beclin-1IBA
01/2021
1Biological ProductsIBA
01/2021
1C-Reactive ProteinIBA
01/2021
1CathepsinsIBA
01/2021
1CholesterolIBA
01/2021
1Fatty Acids (Saturated Fatty Acids)IBA
01/2021
1Hyaluronic Acid (Hyaluronan)IBA
01/2021

Therapy/Procedure

28Therapeutics
02/2022 - 05/2013
4Drug Therapy (Chemotherapy)
08/2021 - 04/2011
3Immunotherapy
10/2021 - 01/2020
3Photochemotherapy (Photodynamic Therapy)
01/2020 - 05/2017
2Hematopoietic Stem Cell Transplantation
11/2020 - 10/2019
1Drug Tapering
01/2022
1Injections
12/2021
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2021